Bardoxolone methyl: Phase II started

Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.), which spun out its pharmaceutical business into AbbVie in January 2013, gained rights from Reata to bardoxolone methyl outside the U.S. and certain ...